Clinical Trials Directory

Trials / Completed

CompletedNCT05013827

Opinions of Company Representatives About Neuromodulation

Opinions of Company Representatives About Neuromodulation for Pain: an Online Survey

Status
Completed
Phase
Study type
Observational
Enrollment
39 (actual)
Sponsor
Moens Maarten · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this online survey is to gain further insight in the goals, expectations and definition of success for neuromodulation for pain, according to neuromodulation company representatives.

Conditions

Interventions

TypeNameDescription
BEHAVIORALFilling in an online surveyCompany representatives are questioned about three aspects: 1) goals in treating patients with neuromodulation for pain, 2) factors that respondents expect to change according to neuromodulation for pain and 3) their definition of success of neuromodulation for pain.

Timeline

Start date
2021-09-02
Primary completion
2021-09-09
Completion
2021-09-09
First posted
2021-08-19
Last updated
2022-01-14

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05013827. Inclusion in this directory is not an endorsement.

Opinions of Company Representatives About Neuromodulation (NCT05013827) · Clinical Trials Directory